Solid Biosciences Inc. SLDB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$191.78M-10.0% | -$174.33M-4.3% | -$167.14M-8.5% | -$154.08M-10.3% | -$139.68M-12.0% | ||
| $1.62M-0.7% | $1.64M-1.3% | $1.66M-1.7% | $1.69M-33.5% | $2.54M+3.3% | ||
| $18.73M+10.7% | $16.91M+18.8% | $14.24M+7.0% | $13.3M+8.6% | $12.25M+16.4% | ||
| $767K+170% | -$1.09M-122% | $4.98M+126% | $2.2M-32.6% | $3.26M+47.9% | ||
| $3.85M-4.9% | $4.05M-26.7% | $5.52M-16.7% | $6.63M+54.9% | $4.28M-10.2% | ||
| —— | —— | —— | —— | —— | ||
| $217K-9.2% | $239K-8.4% | $261K+2,473% | -$11K-113% | $88K0.0% | ||
| -$1.87M-4.5% | -$1.79M-4.8% | -$1.71M-2.7% | -$1.66M-2.5% | -$1.62M+3.4% | ||
| -$171.67M-9.8% | -$156.29M-18.1% | -$132.38M-8.0% | -$122.62M-14.9% | -$106.67M-6.7% | ||
| $1.19M+3.4% | $1.15M+45.6% | $792K+9.7% | $722K+14.4% | $631K-3.5% | ||
| $254.01M+7.7% | $235.89M+3.8% | $227.29M-1.0% | $229.58M+23.2% | $186.33M-8.8% | ||
| —— | —— | —— | —— | —— | ||
| $588K-18.7% | $723K+11.6% | $648K+23.4% | $525K-13.7% | $608K+28.5% | ||
| —— | —— | —— | $303K-1.0% | $306K-33.0% | ||
| $245.35M+25.1% | $196.05M-0.9% | $197.84M-1.0% | $199.92M-2.4% | $204.92M+67.4% | ||
| $85.84M+523% | -$20.3M-568% | -$3.04M-107% | $43.09M— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.18M+16.4% | $1.87M-2.9% | $1.93M-31.3% | $2.81M-16.4% | $3.36M-6.3% | ||
| -$6.05M0.0% | -$6.05M-548% | $1.35M-38.6% | $2.2M-29.0% | $3.1M-34.7% | ||
| —— | $0-100% | $500K-50.0% | $1M-33.3% | $1.5M-25.0% | ||
| $3.85M-4.9% | $4.05M-26.7% | $5.52M-16.7% | $6.63M+54.9% | $4.28M-10.2% | ||
| -$1.87M-4.5% | -$1.79M-4.8% | -$1.71M-2.7% | -$1.66M-2.5% | -$1.62M+3.4% | ||
| —— | —— | —— | —— | —— | ||
| $2.42M+2.0% | $2.37M+2.0% | $2.33M+0.6% | $2.31M+0.3% | $2.31M-3.6% | ||
| $217K-9.2% | $239K-8.4% | $261K+2,473% | -$11K-113% | $88K0.0% | ||
| -$268.88M-50.6% | -$178.5M-10.8% | -$161.1M+18.5% | -$197.6M-8.6% | -$181.9M+3.7% | ||
| —— | —— | —— | $1.68M+8,305% | $20K— | ||
| $12.89M— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | $189.64M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $588K-18.7% | $723K+11.6% | $648K+23.4% | $525K-13.7% | $608K+28.5% | ||
| —— | —— | $293K+1,565% | -$20K-133% | $60K— | ||
| —— | —— | —— | —— | $5M— | ||
| -$1.87M-4.5% | -$1.79M-4.8% | -$1.71M-2.7% | -$1.66M-2.5% | -$1.62M+3.4% | ||
| —— | $0+100% | -$65.25K+50.0% | -$130.5K+33.3% | -$195.75K+25.0% | ||
| —— | $4.18M-0.5% | $4.2M-0.5% | $4.22M-0.5% | $4.24M-0.5% | ||
| —— | $0— | —— | —— | —— | ||
| —— | $91K-50.9% | $185.5K-33.8% | $280K-25.2% | $374.5K-20.1% | ||
| —— | $723K+15.3% | $627.25K+18.0% | $531.5K+22.0% | $435.75K+28.2% | ||
| -$172.86M-9.8% | -$157.44M-18.2% | -$133.17M-8.0% | -$123.34M-14.9% | -$107.3M-6.6% | ||
| -$172.86M-9.8% | -$157.44M-18.2% | -$133.17M-8.0% | -$123.34M-14.9% | -$107.3M-6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
